Assystem - 2018 Register document

7

ANNUAL GENERAL MEETING OF 16 MAY 2019

TEXT OF THE PROPOSED RESOLUTIONS

Article L. 228-92 of the French Commercial Code whose issue may be decided or authorised by the Board of Directors in accordance with either (i) the conditions provided for in Article L. 228-40 of said Code, or (ii) the conditions determined by the Company in compliance with Article L. 228- 36-A of said Code, RESOLVE that if any issue is not taken up in full, the Board of Directors may, in accordance with the law and in the order of its choice, take one or more of the following courses of action provided for in Article L. 225- 134 of the French Commercial Code: ● limit the amount of the issue to the subscriptions received, provided that at least three-quarters of the issue is taken up; ● freely allocate all or some of the unsubscribed securities among the investors of its choice; ● offer all or some of the unsubscribed securities on the open market in France and/or abroad, RESOLVE that the issue price of the shares and other securities that may be issued pursuant to this resolution will be set by the Board of Directors in accordance with Article L. 225-136 (paragraph 1) and Article R. 225-119 of the French Commercial Code. For information purposes, as at the date of this Meeting, in accordance with the applicable legislation, the issue price of shares issued pursuant to this resolution must correspond to at least the weighted average of the prices quoted for the Company’s shares over the three trading days preceding the pricing date, less the legally authorised discount (currently 5%) and adjusted for any differences in the cum-rights dates of the new shares. The issue price of securities carrying rights to shares must be set in such a way that the amount received by the Company at the time of issue plus the amount to be received on conversion, exchange, redemption or exercise of said rights is, for each share issued, at least equal to the issue price defined above, RESOLVE that the Board of Directors will have full powers – which may be delegated as provided for by law – to use this authorisation in accordance with the conditions set by law and the Company’s Articles of Association, and notably to: ● determine the timing and other terms of the issue(s), including the type and characteristics of the securities to be issued (either with or without a premium); ● set (i) the amounts of the issue(s), (ii) the cum-rights date (which may be retroactive) of the issued securities and the method by which they will be paid up, and (iii) the terms and conditions for exercising the rights attached to shares and/or securities carrying rights to shares (i.e. any exchange, conversion, redemption or allocation rights); ● decide on and make any adjustments required in accordance with the applicable laws and regulations and any contractual stipulations in order to protect the rights of holders of securities and other instruments carrying rights to the Company’s shares;

● suspend, where appropriate, the exercise of the rights attached to the securities, for a period not exceeding three months; ● in the case of securities issued as payment for securities of another company tendered as part of a public exchange offer:

● prepare the list of securities tendered to the offer,

● set the terms and conditions of issue, the exchange ratio and any balance to be paid in cash, without applying the pricing method described in this resolution,

● determine how the securities will be issued, and

● more generally, take all necessary measures, enter into any and all agreements, and apply for the admission to trading of the securities issued pursuant to this resolution, RESOLVE that the Board of Directors may: ● at its sole discretion, and when it deems appropriate, charge the costs and fees resulting from the capital increase(s) carried out in accordance with this resolution against the related premiums and deduct from said premiums the amounts necessary to increase the legal reserve to 10% of the new capital after each operation; ● take any and all decisions relating to the admission to trading of the issued securities on Euronext Paris; and ● more generally, take all necessary measures, enter into any commitments and carry out any formalities required for the successful completion of the issue(s) and the resulting capital increase(s), and amend the Company’s Articles of Association to reflect the new capital, RESOLVE that this authorisation is given for a period of 26 months as from the date of this Meeting and supersedes any authorisation previously granted for the same purpose. SIXTEENTH RESOLUTION Authorisation for the Board of Directors to increase the Company’s capital, on an immediate or deferred basis, by issuing ordinary shares and/or equity securities carrying rights to other equity securities of the Company or to the allocation of debt securities and/or securities carrying rights to new shares, by way of a private placement as defined in paragraph II of Article L. 411-2 of the French Monetary and Financial Code, without pre-emptive subscription rights for existing shareholders Having considered the reports of the Board of Directors and the Statutory Auditors, in accordance with Articles L. 225-129, L. 225-129-2, L. 225-129-4, L. 225-135, L. 225-136 and L. 228-91 et seq. of the French Commercial Code and paragraph II of Article L. 411-2 of the French Monetary and Financial Code, the shareholders, GRANT the Board of Directors an authorisation – which may be delegated as provided for by law – to increase the Company’s capital by issuing, on one or more occasions and without pre-emptive subscription rights for existing shareholders, (i) ordinary shares of the Company, and/or (ii) equity securities carrying rights to other equity

188

ASSYSTEM

REGISTRATION DOCUMENT 2018